Ovarian Metastasis from Non-Small Cell Lung Cancer Responding to Erlotinib.
10.12771/emj.2015.38.1.46
- Author:
Ik Ju JUNG
1
;
Seung Taek LIM
;
Yeon Seok CHOI
;
Tae Soo JANG
;
Sun Hee OH
;
Joo Ah LEE
;
Do Yeun CHO
Author Information
1. Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea. dycho@kyuh.ac.kr
- Publication Type:Case Report
- Keywords:
Non-small cell lung cancer;
Metastasis;
Erlotinib
- MeSH:
Carcinoma, Non-Small-Cell Lung*;
Humans;
Lung;
Lung Neoplasms;
Neoplasm Metastasis*;
Ovarian Neoplasms;
Receptor, Epidermal Growth Factor;
Erlotinib Hydrochloride
- From:The Ewha Medical Journal
2015;38(1):46-49
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Ovarian cancer is generally primary cancer and less frequently originates from metastasis from non-gynecological cancer. Ovarian metastasis from lung cancer represents only 2~4% of all ovarian metastatic cancers. We report a case of ovarian metastasis of non-small cell lung cancer with epidermal growth factor receptor mutation. The patient underwent cytoreductive surgery for the ovarian mass and erlotinib therapy for the metastatic lung cancer. Erlotinib therapy markedly decreased the size of lung mass.
